Xanthopsia (Halo Effect)

What is Xanthopsia (halo effect)?

Xanthopsia is a visual disturbance in which a person perceives a persistent yellowish tint over the entire visual field. When the phenomenon appears as a luminous ring or “halo” around lights, it is often called the halo effect. The discoloration can range from a subtle golden hue to a striking yellow glare that masks other colors. Xanthopsia is not a disease itself; rather, it is a symptom of underlying ocular or systemic problems that alter the way the retina or visual pathways process light.

The condition can be temporary (e.g., after taking certain medications) or chronic (e.g., in advanced cataract). Because it interferes with color discrimination and depth perception, it may affect daily activities such as driving, reading, or operating machinery.

Common Causes

Below are the most frequently reported causes of xanthopsia or a halo‑type visual tint. In many cases, more than one factor is involved.

• Medications:
  • Digitalis (digoxin) – classic cause of yellow‑green vision.
  • Quinine or chloroquine (used for malaria and autoimmune disease).
  • Topiramate (migraine prophylaxis) – can produce peripheral halos.
• Cataracts: The yellowing of the natural lens scatters short‑wavelength light, creating a warm halo around lights, especially at night.
• Retinal disorders:
  • Macular degeneration.
  • Retinal detachment (early stages may present with color distortion).
• Corneal edema or swelling: Fluid accumulation changes the cornea’s refractive index, producing halos and a yellow tint.
• Glaucoma medications: Certain topical agents (e.g., pilocarpine) can cause transient halos.
• Systemic diseases:
  • Hyperbilirubinemia (jaundice) – excess bilirubin can deposit in the retina.
  • Diabetes mellitus – fluctuating blood glucose can temporarily alter lens clarity.
• Exposure to toxic substances: Heavy metals (lead, mercury) or industrial chemicals can affect retinal pigment.
• Neurological conditions: Lesions in the visual cortex or optic radiations (e.g., from stroke) may produce color‑contrast abnormalities, including yellowing.
• Eye trauma: Penetrating injuries or blunt trauma that damage the cornea or lens can cause halos.
• Age‑related changes: Natural lens yellowing over decades can mimic mild xanthopsia, especially in low‑light situations.

Associated Symptoms

Patients with xanthopsia often report additional visual or systemic signs, which help clinicians narrow the cause.

• Glare or difficulty seeing at night (nyctalopia).
• Blurry or double vision (diplopia).
• Reduced contrast sensitivity.
• Eye pain, redness, or watering.
• Headache or eye strain after reading.
• Systemic symptoms such as fatigue, nausea, or palpitations (particularly with digoxin toxicity).
• Sudden loss of peripheral vision or “curtain” effect (suggestive of retinal detachment).

When to See a Doctor

While occasional halos after bright lights can be benign, the following situations merit prompt medical evaluation:

• Sudden onset of a yellow tint or halos.
• Accompanying eye pain, redness, or discharge.
• Vision loss, even partial, or a feeling that objects are “floating.”
• Recent change in medication dosage or a new prescription.
• History of diabetes, heart disease, or liver disease with new visual changes.
• Symptoms that interfere with driving, operating equipment, or reading.

Diagnosis

Diagnosing xanthopsia involves a systematic assessment to pinpoint the underlying cause.

1. Clinical History

• Medication review (including over‑the‑counter and herbal supplements).
• Onset, duration, and pattern of visual changes.
• Associated systemic symptoms (e.g., jaundice, heart palpitations).
• Occupational exposures and recent eye trauma.

2. Vision Tests

• Visual acuity and refraction.
• Color vision testing (Ishihara plates, Farnsworth‑Munsell).
• Contrast sensitivity measurement.

3. Eye‑Specific Examination

• Slit‑lamp biomicroscopy: evaluates cornea, lens, and anterior chamber for edema, cataract, or deposits.
• Fundoscopy (direct/indirect ophthalmoscopy): checks retina, macula, and optic disc for degenerative changes.
• Pachymetry: measures corneal thickness if edema is suspected.
• Optical coherence tomography (OCT): high‑resolution imaging of retina and macula.

4. Laboratory & Systemic Tests

• Serum digoxin level if on digitalis.
• Liver function tests & bilirubin levels for jaundice.
• Blood glucose and HbA1c for diabetic patients.
• Heavy‑metal screening when occupational exposure is possible.

Treatment Options

Therapy is directed at the root cause; while the visual hue may resolve slowly, supportive measures can improve comfort.

Medication‑Related Causes

• Adjust or discontinue the offending drug under physician guidance (e.g., lower digoxin dose).
• Antidotes for toxicity, such as digoxin‑specific antibody fragments (Digibind) for severe digitalis poisoning.

Cataract‑Related Halos

• Prescription of anti‑glare glasses with yellow‑tint filters to reduce scatter.
• Surgical removal of the cloudy lens (phacoemulsification) with intra‑ocular lens implantation.

Corneal Edema or Swelling

• Hypertonic (5%) saline eye drops or ointment.
• Topical corticosteroids for inflammatory edema (short‑term use).
• Control of intra‑ocular pressure if edema is secondary to glaucoma.

Retinal or Macular Disease

• Anti‑VEGF injections for neovascular age‑related macular degeneration.
• Laser photocoagulation or pneumatic retinopexy for early retinal detachment.
• Nutritional supplements (vitamin C, vitamin E, zinc, lutein) as recommended by the AREDS2 study.

Systemic Management

• Treat hyperbilirubinemia (phototherapy, exchange transfusion) in severe jaundice.
• Optimize diabetes control to reduce lens protein glycation.
• Chelation therapy for heavy‑metal poisoning, when indicated.

Home & Supportive Care

• Use of non‑reflective, matte screen protectors on computers and smartphones.
• Maintain adequate ambient lighting; avoid bright headlights directly in the line of sight.
• Regular eye‑drop regimen (lubricants) if dryness contributes to glare.
• Adopt a balanced diet rich in antioxidants (leafy greens, berries, omega‑3 fatty acids).

Prevention Tips

• Take prescribed medications exactly as directed; never self‑adjust dosages.
• Schedule routine eye exams (every 1–2 years for adults, annually after age 40) to detect early cataract or retinal changes.
• Protect eyes from UV radiation with sunglasses that block 99‑100 % UVA/UVB.
• Manage chronic illnesses (diabetes, hypertension, liver disease) through lifestyle and medication adherence.
• Limit exposure to bright, flickering lights and wear safety goggles when working with lasers or intense illumination.
• Stay hydrated and avoid smoking, which accelerates cataract formation.
• Inform your ophthalmologist of any new drugs, even over‑the‑counter supplements.

Emergency Warning Signs

Sources: Mayo Clinic, National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), American Academy of Ophthalmology, Cleveland Clinic, World Health Organization (WHO), and peer‑reviewed ophthalmology journals.